BMS Korea to expand more business tie-up with local partners.

Published: 2002-08-23 06:56:00

Updated: 2002-08-23 06:56:00

While most of foreign multinational drug corporations recalled their product licences from the domestic business partners, BMS Korea is rather expanding more business tie-ups with domestic partners.

BMS Korea made a 5-year termed exclusive distribution agreement on Aug. 21 for Serzone tablet, ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK